SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00460 SIHUAN PHARM

Trading 03-05 15:33:07

1.400

+0.050

+3.70%

High1.420	Low1.370	Vol33.46M
Open1.370	D1 Closing1.350	Amplitude3.70%
Mkt Cap12.80B	Tradable Cap12.80B	Total Shares9.15B
T/O46.77M	T/O Rate0.37%	Tradable Shares9.15B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"SIHUAN PHARM","latestPrice":1.4,"timestamp":1772695984372,"preClose":1.35,"halted":0,"volume":33460000,"delay":0,"changeRate":0.0370370370370369,"floatShares":9146000000,"shares":9146000000,"eps":-0.023382,"marketStatus":"Trading","change":0.05,"latestTime":"03-05 15:33:07","open":1.37,"high":1.42,"low":1.37,"amount":46772185,"amplitude":0.037037,"askPrice":1.4,"askSize":4406000,"bidPrice":1.39,"bidSize":1081000,"shortable":3,"etf":0,"ttmEps":-0.009629,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772698200000},"marketStatusCode":2,"adr":0,"listingDate":1288195200000,"exchange":"SEHK","adjPreClose":1.35,"dividendRate":0.007786,"openAndCloseTimeList":[[1772674200000,1772683200000],[1772686800000,1772697600000]],"volumeRatio":0.820236,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00460/wiki","defaultTab":"wiki","newsList":[{"id":"1126363613","title":"SIHUAN PHARM (00460) Rises Over 5% in Morning Session as Xuan Yue Ning® Gains Third Indication Approval from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1126363613","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126363613?lang=en_us&edition=fundamental","pubTime":"2026-03-05 11:36","pubTimestamp":1772681786,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) saw an increase of more than 5% before the midday break. As of the time of writing, the stock had risen by 5.19% to HK$1.42, with a turnover of HK$19.4691 million. On March 3,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","VT","BK1593","BK4585","BK1515","BK4588","BK1191","BK1600","VXUS"],"gpt_icon":0},{"id":"2616346818","title":"BRIEF-Sihuan Pharma Reports Marketing Approval For Bireociclib Tablets Granted By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346818","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616346818?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:25","pubTimestamp":1772533550,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Reports Marketing Approval For Bireociclib Tablets Granted By NMPAMarch 3 (Reuters) - Sihuan Pharmaceutical 0460.HK:MARKETING APPROVAL FOR BIREOCICLIB TABLETS GRANTED BY NMPAFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZQ1JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","BK1191","00460","BK1600"],"gpt_icon":0},{"id":"1105924238","title":"Sihuan Pharmaceutical (0460) Gains NMPA Approval for Third Indication of Bireociclib in First-Line HR+/HER2- Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1105924238","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105924238?lang=en_us&edition=fundamental","pubTime":"2026-03-03 17:07","pubTimestamp":1772528876,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (0460) announced that the National Medical Products Administration of China granted marketing approval for the third indication of its innovative drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"2616173103","title":"Sihuan Pharma - Marketing Approval for Bireociclib Tablets Granted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2616173103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616173103?lang=en_us&edition=fundamental","pubTime":"2026-03-03 16:44","pubTimestamp":1772527442,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZQ1JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1593","BK1191","BK1515","00460"],"gpt_icon":0},{"id":"2616127853","title":"China NMPA grants Xuanzhu Biopharmaceutical approval for Xuanyuening in first-line HR+/HER2- advanced breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2616127853","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616127853?lang=en_us&edition=fundamental","pubTime":"2026-03-03 16:39","pubTimestamp":1772527147,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical Co. Ltd. said China’s National Medical Products Administration  has granted marketing approval for a new indication of its Bireociclib tablets  in combination with an aromatase inhibitor for first-line treatment of HR+/HER2- advanced breast cancer. The company said this is Bireociclib’s third approved indication in China, following approvals for use with fulvestrant and as a monotherapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL9hzLjt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","BK1593","00460","02575","BK1191"],"gpt_icon":0},{"id":"1150892152","title":"Sihuan Pharmaceutical (00460) Publishes February 2026 Monthly Return, Confirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1150892152","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150892152?lang=en_us&edition=fundamental","pubTime":"2026-03-02 16:23","pubTimestamp":1772439810,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (00460) has released its monthly return covering the period ended 28 February 2026. According to the report, the authorized share capital remains at 1.00...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"2613083972","title":"Xuanzhu Biopharmaceutical to Join Hang Seng Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2613083972","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613083972?lang=en_us&edition=fundamental","pubTime":"2026-02-23 10:01","pubTimestamp":1771812091,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group  said its non-wholly owned subsidiary Xuanzhu Biopharmaceutical  is due for inclusion to the Hang Seng Composite Index on March 9, according to a Hong Kong bourse filing Friday.Xuanzhu Biopharmaceutical went public in Hong Kong in October of last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00460","BK1600","BK1191","BK1515","BK1593","02575"],"gpt_icon":0},{"id":"1196396808","title":"Sihuan Pharmaceutical (0460) Announces Xuanzhu Biopharm (2575) Inclusion in Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1196396808","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196396808?lang=en_us&edition=fundamental","pubTime":"2026-02-22 18:21","pubTimestamp":1771755696,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (0460) announced that its non-wholly-owned subsidiary Xuanzhu Biopharmaceutical Co., Ltd. (2575) has been included as a constituent stock of the Hang Seng...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"2613222177","title":"**Xuanzhu Biopharmaceutical Joins Hang Seng Composite Index**Xuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613222177","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613222177?lang=en_us&edition=fundamental","pubTime":"2026-02-22 18:06","pubTimestamp":1771754767,"startTime":"0","endTime":"0","summary":"**Xuanzhu Biopharmaceutical Joins Hang Seng Composite Index** Xuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026. Xuanzhu Biopharmaceutical Co., Ltd. said it will be **added** as a constituent stock of the **Hang Seng Composite Index** following the Hang Seng Indexes Company’s quarterly review for the period ended Dec. 31, 2025, with the change effective March 9, 2026. The company said the inclusion reflects investor recognition of its value and growth potential and is expected to improve share liquidity and broaden its investor base.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260222:nNDL2nmBT7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1593","00460","BK1191","BK1515","02575"],"gpt_icon":0},{"id":"2612405689","title":"A Look At Sihuan Pharmaceutical Holdings Group (SEHK:460) Valuation After New Earnings Guidance And Segment Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2612405689","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612405689?lang=en_us&edition=fundamental","pubTime":"2026-02-19 15:42","pubTimestamp":1771486935,"startTime":"0","endTime":"0","summary":"Guidance-driven spotlight on Sihuan Pharmaceutical Holdings Group\nSihuan Pharmaceutical Holdings Group (SEHK:460) caught investor attention after issuing unaudited 2025 earnings guidance, indicating at least RMB 2,500 million in revenue and RMB 150 million in net profit for the year.\nSee our latest analysis for Sihuan Pharmaceutical Holdings Group.\nThe earnings guidance lands after a strong run in the share price, with a 30 day share price return of 25.19% and a year to date gain of 28.12%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/a-look-at-sihuan-pharmaceutical-holdings-group-sehk460-valua","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/a-look-at-sihuan-pharmaceutical-holdings-group-sehk460-valua","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1191","00460","BK1515","BK1600","BK1593"],"gpt_icon":0},{"id":"1131185906","title":"Sihuan Pharmaceutical (0460) Issues Positive Profit Alert with Strong Growth in Medical Aesthetics and Innovative Drug Segments","url":"https://stock-news.laohu8.com/highlight/detail?id=1131185906","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131185906?lang=en_us&edition=fundamental","pubTime":"2026-02-10 23:42","pubTimestamp":1770738165,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (HKEX:0460) released an announcement stating it expects revenue of no less than RMB2,500 million for the year ended 31 December 2025, marking a 30% increase...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"2610262130","title":"BRIEF-Sihuan Pharma Sees Net Profit Of Not Less Than RMB150 Million For Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2610262130","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610262130?lang=en_us&edition=fundamental","pubTime":"2026-02-10 23:17","pubTimestamp":1770736620,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Sees Net Profit Of Not Less Than RMB150 Million For YearFeb 10  - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:SEES NET PROFIT OF NOT LESS THAN RMB150 MILLION FOR YEAREXPECTS REVENUE OF AT LEAST RMB2,500 MILLION IN FYFurther company coverage: 0460.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00460","BK1593","BK1515","BK1600"],"gpt_icon":0},{"id":"1192554954","title":"Sihuan Pharmaceutical Issues Positive Profit Alert, Anticipates Revenue Exceeding RMB 25 Billion for Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1192554954","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192554954?lang=en_us&edition=fundamental","pubTime":"2026-02-10 23:07","pubTimestamp":1770736068,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical (00460) has announced a positive profit alert. Based on a preliminary assessment of the company's unaudited consolidated management accounts and current information available to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","00460","BK1191","BK1515","BK1600"],"gpt_icon":0},{"id":"2610629912","title":"Sihuan Pharma Sees Net Profit of Not Less Than RMB150 Mln for Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629912?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:54","pubTimestamp":1770735272,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1600","BK1593","00460"],"gpt_icon":0},{"id":"2610629911","title":"Sihuan Pharma - Expects Revenue of at Least RMB2,500 Mln in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629911?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:54","pubTimestamp":1770735272,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60OR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1593","BK1600","00460","BK1191"],"gpt_icon":0},{"id":"2610629949","title":"Sihuan Pharmaceutical Expects Significant Profit Growth for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629949","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629949?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:54","pubTimestamp":1770735252,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. has issued a positive profit alert for the year, indicating a significant improvement in business performance. The company highlighted that its innovative drug business has entered a harvest period, with subsidiaries Xuanzhu Biopharm and Huisheng Biopharm achieving notable year-on-year revenue growth. Sihuan Pharmaceutical also reported a transition from an investment phase to a revenue-generating phase in its innovative drug segment, leading to a marked enhancement in its profit structure. Additionally, the company noted substantial equity appreciation gains following the successful spin-off listing of Xuanzhu Biopharm and multiple rounds of share repurchases, which have strengthened its financial position and driven breakthroughs in profitability.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL137MZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575","BK1515","BK1593","BK1600","00460","BK1191"],"gpt_icon":0},{"id":"2610343886","title":"Sealand Securities Starts Sihuan Pharmaceutical Holdings Group at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2610343886","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610343886?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:16","pubTimestamp":1770635761,"startTime":"0","endTime":"0","summary":"Sealand Securities Starts Sihuan Pharmaceutical Holdings Group at Buy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","00460","BK1593","BK1515","BK1600"],"gpt_icon":0},{"id":"1134537202","title":"Sihuan Pharmaceutical (00460) Announces January 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1134537202","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134537202?lang=en_us&edition=fundamental","pubTime":"2026-02-02 17:51","pubTimestamp":1770025879,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (00460) reported that, as of January 31, 2026, the authorized share capital remains at 100,000,000,000 ordinary shares with a par value of HKD 0.01 each,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"1181433567","title":"Zhytong Hong Kong Stock Analysis | UK Prime Minister's China Visit Boosts Market Sentiment, Price Hike Concepts Strengthen Collectively","url":"https://stock-news.laohu8.com/highlight/detail?id=1181433567","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181433567?lang=en_us&edition=fundamental","pubTime":"2026-01-27 19:18","pubTimestamp":1769512731,"startTime":"0","endTime":"0","summary":"Overnight, U.S. stocks staged a collective rebound; if they continue to rise, they might very well set new historical highs. Hong Kong stocks also gapped up directly today, closing 1.35% higher, with...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588545730.USD","LU0054450605.USD","LU0737861772.HKD","LU0561508036.HKD","LU1251922891.USD","81299","LU0540923850.HKD","LU1242518931.SGD","LU1328615791.USD","LU0197773160.USD","LU1770036033.HKD","IE0032834883.USD","LU0572939691.SGD","LU0630378692.HKD","LU0738912210.USD","LU0315178854.USD","LU0039217434.USD","LU1688375341.USD","LU0314109678.HKD","LU0158827781.USD","SG9999012728.SGD","IE0034224299.USD","518880","IAU","01299","02676","BK1600","03986","LU0880133367.SGD","LU0675040207.SGD","LU1720050803.USD","LU0886674414.USD","LU1719994722.HKD","LU0274383008.USD","LU0871576103.HKD","LU0516423091.SGD","LU0228659784.USD","LU1642822792.SGD","LU0266512473.USD","LU2265009873.SGD","SG9999000327.SGD","LU1951186391.HKD","LU1993786604.SGD","SG9999000459.SGD","LU1981816686.USD","LU1323998911.USD","SG9999012736.USD","LU1770034418.SGD","SG9999004303.SGD","BK4585","LU0630378429.USD","LU1102505762.USD","LU0702159343.USD","LU0345776255.USD","IE00B8L5B284.USD","01385","BK1544","IE00B031J352.USD","03896","LU0307460666.USD","LU0577902371.SGD","LU0918141705.HKD","LU2039709279.SGD","LU2213484517.USD","02691","LU0865486749.SGD","SGXZ23171101.USD","LU0588546209.SGD","LU0359201612.USD","LU1211504680.USD","LU0823426480.USD","LU1804176565.USD","LU1813983027.USD","LU1130305938.SGD","LU1226287792.SGD","LU0594300179.USD","BK1589","IE0008368742.USD","LU0543330483.HKD","LU0315179316.USD","LU0588545490.SGD","06869","IE00B8HQ1Z84.USD","LU0320764599.SGD","LU0509642566.USD","LU0251143458.SGD","LU1807302812.USD","LU2097828714.EUR","LU1282648689.USD","BK1592","BK1183","QOmain","LU0210527791.USD","LU0289961442.SGD","LU0572944931.SGD","02259","00981","LU0577902611.USD","LU1712237335.SGD","LU0264606111.USD","BK1191","LU1504937902.USD","LU0396098781.USD","LU0823397103.USD","IE00BF5LJ272.USD","LU2028103732.USD","SG9999014021.USD","02899","LU0672654166.SGD","LU0072462343.USD","LU0164880469.USD","SG9999001689.USD","GCmain","HK0000306701.USD","LU1831875114.USD","LU1048588211.SGD","IE0003851619.USD","LU0049853897.USD","LU0737861699.HKD","01848","LU0708995583.HKD","LU0348816934.USD","LU0029875118.USD","IE0003795394.USD","LU0345775950.USD","LU0955669360.SGD","LU1046422090.SGD","GB00BDT5M118.USD","SG9999014039.USD","03899","BK1593","LU0878004406.USD","LU2153592121.USD","BK1610","SG9999014013.SGD","BK1134","LU1224709979.USD","LU2226246903.HKD","02357","LU0348766576.USD","LU0261947096.USD","LU0971096721.USD","LU0955648018.USD","HK0000288743.USD","LU0345780521.USD","LU0348825331.USD","LU2023251221.USD","LU1226287875.USD","SG9999004220.SGD","LU0702159699.USD","LU0269904917.USD","SG9999012710.SGD","LU0878005551.USD","LU1048484197.HKD","SGXZ62798434.SGD","LU1629966141.USD","LU0072913022.USD","LU0797268264.HKD","LU1023057109.AUD","LU1880383366.USD","BK1124","LU1363072403.SGD","LU1166156734.SGD","LU2125910500.SGD","IE00BFXG0V08.USD","BK1550","LU0165289439.USD","LU1171460220.USD","LU2089284900.SGD","LU0823426308.USD","MGCmain","LU1568876251.USD","LU0169518387.USD","LU2177674079.SGD","LU2097828474.EUR","LU2399975544.HKD","LU0979878070.USD","LU1044875133.USD","LU0067412154.USD","LU0320764755.SGD","BK1184","LU0456854461.SGD","LU0348814723.USD","LU0192582467.USD","LU0348784397.USD","159934","LU2242644610.SGD","LU0328353924.USD","SG9999001846.SGD","BK1607","BK4588","LU0128522157.USD","BK1163","LU1119993845.HKD","LU1769817096.USD","LU1568876335.HKD","IE0008369823.USD","IE00BZ08YS42.EUR","LU0828237940.HKD","LU1439103000.SGD","LU0784639295.USD","LU0541502299.USD","GLD","LU1734074674.USD","LU1044874839.SGD","LU2152927971.USD","NUGT","LU0140636845.USD","LU0511384066.AUD","LU1821325948.USD","IE00B5TLWC47.USD","LU0345780281.USD","LU2348774022.SGD","LU0348783233.USD","LU0463099449.HKD","LU1152091754.HKD","HK0000320223.HKD","LU0228367735.SGD","LU0214875030.USD","LU0819123356.HKD","LU0828238088.HKD","1OZmain","AAGIY","BK1211","LU0823039010.USD","LU1226288253.USD","LU1188198961.HKD","LU1794554557.SGD","LU1102505929.USD","LU0469268626.HKD","SG9999002562.SGD","LU0762542818.HKD","IE00B3T34201.USD","LU0106259558.USD","LU0266512127.USD","LU2449936058.SGD","LU0188438112.USD","LU1328277881.USD","LU1880383440.USD","LU0329678337.USD","GLDM","HK0000252160.HKD","BK1584","SGCmain","LU0158827948.USD","LU0057025933.USD","LU0577902298.EUR","02628","LU0472753341.HKD","LU0882747503.HKD","LU0605514214.HKD","LU2089283258.USD","LU0132412106.USD","SG9999006597.SGD","LU0149534421.HKD","00522","LU0261950470.USD","LU0326950275.SGD","LU0197773673.USD","LU1983260115.SGD","LU0449509016.USD","HK0000288784.HKD","LU0054237671.USD","LU0414403682.SGD","IE00BZ08YT58.USD","BK1613","LU0831103253.SGD","LU2153591404.USD","LU0196878994.USD","IE00B031HW06.USD","BK1147","LU0557290698.USD","LU0048597586.USD","IE00BYQQ9H92.USD","LU1282649141.HKD","LU1152091168.USD","LU0048575426.USD","LU1242518857.USD","LU1226287529.USD","LU1956131251.USD","IE00BZ08YR35.GBP","LU1282649810.SGD","LU0227179875.USD","BK1505","LU1961090484.USD","LU0117844026.USD","IE00B543WZ88.USD","LU1655091459.SGD","LU0762540952.USD","LU3063872942.SGD","LU0327786744.USD","LU0417516738.SGD","LU0329678170.USD","LU0831093199.SGD","LU0164865239.USD","UGL","LU1439102457.SGD","BK1522","LU0359202008.SGD","LU0594300419.USD","BK1614","LU2097828631.EUR","LU2097828557.USD","LU0819121731.USD","LU0287142896.SGD","LU0577902538.SGD","BK1198","LU2008162690.USD","BK1523","LU2087589342.USD","LU2257852520.SGD","LU2271345857.HKD","LU0052750758.USD","LU0898667661.SGD","SG9999002463.SGD","IE00B031HY20.USD","BK4504","LU0348767384.USD","LU1303224171.USD","SGXZ86797644.SGD","01347","LU0048580855.USD","IE00BKZH1Z71.USD","LU0821914370.USD","HK0000165453.HKD","LU0449515922.USD","LU1481012133.USD","LU0516423174.USD","LU0823397285.USD","LU1196710864.SGD","LU0417516571.SGD","BK1169","LU0456842615.SGD","LU0181495838.USD","LU0061477393.USD","HK0000252152.HKD","HK0000500386.USD","LU0244354667.USD","BK1515","LU0289739343.SGD","BK1506","LU0611395673.USD","LU0877626530.USD","LU0856984785.SGD","IE0009570106.USD","LU0634319403.HKD","LU0043850808.USD","00460","SG9999014005.SGD","LU1226288170.HKD","LU2348773727.SGD","LU0456846285.SGD","LU0048388663.USD","LU2097828805.USD","LU0069063385.USD","LU1008478684.HKD","LU0577902454.USD","LU1623119135.USD","01093","LU0488056044.USD","LU0516422366.SGD","LU0516422952.EUR","LU0648948544.HKD","LU0762541174.USD","LU0326948709.USD","LU0650527681.SGD","LU0572940350.SGD","LU1481107354.HKD","LU0823038988.USD","LU0251144936.SGD","DUST","LU1282649067.USD","LU0607220059.USD","LU0235996351.USD","LU1960683339.HKD","02588","LU2111349929.HKD","BK1526","LU0873338254.USD","LU0173614495.USD","LU0531971595.HKD","LU0096374516.USD","LU0348827113.USD","LU0441854154.USD","SG9999001903.USD","LU1044876610.USD","LU1808992512.USD","LU0011963245.USD","LU0106252389.USD","LU0384037296.USD","LU0955623706.USD","LU1048596156.SGD","LU2543165471.USD","LU0348788117.USD","LU0593848301.USD","SGUmain","BK1149","HK0000320264.USD","LU0348735423.USD","BK4535","LU0261950983.USD","HK0000306685.HKD","LU1105468828.SGD","SG9999012744.USD","LU0370786039.SGD","LU0163747925.USD","LU0501845795.SGD","LU1769817179.HKD","01336","IE00B0169L03.USD","LU0918141887.USD","LU0084288322.USD","IE00B97KM107.HKD","IE0008368411.USD","IE00B067MR52.USD","BK1521","BK1594","IE00B5MMRT66.SGD","LU0541501648.USD","LU0149721374.USD","GDX","LU0211977185.USD","LU0205439572.USD","LU0588545904.SGD","IE0031814852.USD","LU0828237510.HKD","IE0032431581.USD","LU2045819591.USD","LU0516422440.USD","LU0417516902.SGD"],"gpt_icon":1},{"id":"1139201348","title":"SIHUAN PHARM (00460) Surges Over 9% Again as Institutions Favor Accelerated Dual Growth from Aesthetic and Innovation Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1139201348","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139201348?lang=en_us&edition=fundamental","pubTime":"2026-01-27 12:10","pubTimestamp":1769487025,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) rose more than 9% again. As of writing, the stock was up 8.9% to HK$1.59, with a turnover of HK$150 million. On the news front, SIHUAN PHARM recently announced that six new...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1161","159992","BK1574","BK1593","00460","BK1191","BK1515","BK1600"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sihuanpharm.com.cn","stockEarnings":[{"period":"1week","weight":-0.1563},{"period":"1month","weight":-0.129},{"period":"3month","weight":0.0075},{"period":"6month","weight":-0.1763},{"period":"1year","weight":1.2277},{"period":"ytd","weight":0.0976}],"compareEarnings":[{"period":"1week","weight":-0.0566},{"period":"1month","weight":-0.057},{"period":"3month","weight":-0.0265},{"period":"6month","weight":-0.0066},{"period":"1year","weight":0.1006},{"period":"ytd","weight":-0.0149}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company primarily engaged in the research and development, manufacture and sale of pharmaceutical products and aesthetic products. The Company operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.119825},{"month":2,"riseRate":0.5,"avgChangeRate":0.000395},{"month":3,"riseRate":0.3125,"avgChangeRate":-0.032344},{"month":4,"riseRate":0.571429,"avgChangeRate":0.046025},{"month":5,"riseRate":0.428571,"avgChangeRate":0.020898},{"month":6,"riseRate":0.571429,"avgChangeRate":0.003131},{"month":7,"riseRate":0.571429,"avgChangeRate":0.007501},{"month":8,"riseRate":0.5,"avgChangeRate":-0.014353},{"month":9,"riseRate":0.214286,"avgChangeRate":-0.045133},{"month":10,"riseRate":0.571429,"avgChangeRate":0.029461},{"month":11,"riseRate":0.466667,"avgChangeRate":0.008386},{"month":12,"riseRate":0.4,"avgChangeRate":-0.017588}],"exchange":"SEHK","name":"SIHUAN PHARM","nameEN":"SIHUAN PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SIHUAN PHARM(00460) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SIHUAN PHARM,00460,SIHUAN PHARM股票,SIHUAN PHARM股票老虎,SIHUAN PHARM股票老虎国际,SIHUAN PHARM行情,SIHUAN PHARM股票行情,SIHUAN PHARM股价,SIHUAN PHARM股市,SIHUAN PHARM股票价格,SIHUAN PHARM股票交易,SIHUAN PHARM股票购买,SIHUAN PHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SIHUAN PHARM(00460) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}